Skip to main content

Portfolio

HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.

Overview as at 30 September 2018

Currency allocation of assets

Emphasis on US dollar investments

56 340 US dollar (USD) 75 Euro (EUR) 10 Other currencies (CAD, DKK, INR, SEK) 8 British pound (GBP) 4 Swiss franc (CHF) 3 #008D6C #A1564C #89733F #87AFB1 #54465D #D4A42A #B1AB8E #255B8E #5C5A4F #323D4A
Allocation of assets

Mainly invested in private companies or in companies originating
from the private companies portfolio.

62 340 Public companies 60 Private companies 21 Funds 10 Cash and cash equivalents 6 Other assets 3 #008D6C #A1564C #89733F #87AFB1 #54465D #D4A42A #B1AB8E #255B8E #5C5A4F #323D4A
Development phase of portfolio companies

Mainly invested in revenue generating companies or in companies with products at an advanced stage of development.

69 90 Products on the market 25 Phase III 30 Phase II 25 Profitable 14 Phase I 4 Preclinical 2 #008D6C #A1564C #89733F #87AFB1 #54465D #D4A42A #B1AB8E #255B8E #5C5A4F #323D4A
Therapeutic area of the lead product of portfolio companies

Broadly diversified areas of activity.

79 350 Others 26 Oncology 18 Orphan diseases 21 Central nervous system 12 Medical technology / diagnostics 3 Respiratory diseases 5 Autoimmune diseases 7 Metabolic diseases 4 Infectious diseases 4 #008D6C #A1564C #89733F #87AFB1 #54465D #D4A42A #B1AB8E #255B8E #5C5A4F #323D4A